TABLE 7.
Authors, Year | Participants Lost to Follow-Up | Months of Follow-Up | Morning Blood Sampling | Participants Free of Other Treatments That Could Profoundly Affect Testosterone Levels | Randomized Participant Groups | Double-Blinded Study | For-Profit Funding Source |
---|---|---|---|---|---|---|---|
Vaughan et al, 2007 | 23/69 (33%) | 36 | Yes | Yes | Yes | Yes | No |
Lu et al, 2006 | 9/47 (19%) | 24 | No | Yes | Yes | Yes | Partial |
Sih et al, 1997 | 10/32 (31%) | 12 | No | No | Yes | Yes | No |
Cherrier et al, 2003 | 0/12 (0%) | 6 | Yes | Yes | Yes | Yes | Partial |
Tan and Pu, 2003 | Not reported | 12 | No | No | Yes | Not reported | No |
Kenny et al, 2002 | 23/67 (33%) | 12 | No | Yes | Yes | Not reported | No |
Cherrier et al, 2005 | 3/32 (9%) | 3 | No | Yes | Yes | Yes | No |
Kenny et al, 2004 | 0/11 (0%) | 2.5 | Yes | No | Yes | Yes | No |
Fukai et al, 2010 | Not reported | 6 | Yes | No | No | Not reported | No |